ArticleMolecular systems biology2026
Macrophage response specificity to ligand mixtures is improved by signaling pathway antagonism.
Article in Molecular systems biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Macrophages function as immune sentinels that distinguish diverse threats and mount appropriate responses. This stimulus-response specificity (SRS) is partly encoded in the dynamics of the NFκB transcription factor. While most studies examine single ligands, physiological exposures involve complex multi-ligand mixtures. Using a mathematical model that captures heterogeneous single-cell NFκB responses, we generated simulation datasets for mixtures of up to five ligands and validated key predictions with live-cell microscopy. Following iterative refinement of the model, we quantified SRS with Wasserstein distance and machine learning classification and found that NFκB temporal coding can partially convey the presence of specific ligands within mixtures. By generating simulation datasets across all ligand pairs at doses spanning the full responsiveness range, we found several cases of synergy and antagonism between stimuli. Antagonism was for example the result of a limited supply of stimulus-cofactor CD14 or endosomal transport capacity. Synergy depended on ultra-sensitive IKK activation in cells with low receptor expression. While synergy does not enhance SRS, antagonism between TLR9 and TLR3 signaling pathways due to endosomal transport competition may enhance the distinguishability of CpG-pIC from ligand mixtures. These studies therefore identified antagonism mechanisms in signaling pathways as key to maintaining immune specificity under complex conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.